The Effect of Polyphenolic Composition BP-C3 on the Efficacy and Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing Soft Tissue Sarcomas Induced by Benzo[a]pyrene.
blood count
chemotherapy
cyclophosphamide
polyphenolic composition BP-C3
soft tissue sarcoma
toxicity
Journal
Integrative cancer therapies
ISSN: 1552-695X
Titre abrégé: Integr Cancer Ther
Pays: United States
ID NLM: 101128834
Informations de publication
Date de publication:
Historique:
entrez:
8
3
2019
pubmed:
8
3
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
This study aimed to evaluate the effect of lignin-derived polyphenolic composition BP-C3 on the efficacy and hematological toxicity of cyclophosphamide (CPA). Male and female Swiss-H derived mice bearing benzo[a]pyrene-induced soft tissue sarcomas were treated with CPA 300 mg/kg, BP-C3 75 mg/kg, or a combination. Tumor growth inhibition in male mice treated with CPA, BP-C3, or a combination of CPA and BP-C3 was significant and corresponded to 78%, 45%, and 82%, respectively, on day 21 after CPA administration on day 0. In female mice, tumor growth inhibition was 58%, -11%, and 35% when treated with CPA, BP-C3, or a combination of CPA and BP-C3, respectively. CPA administration resulted in significant hematological toxicity evidenced by a decreased white blood cell count on day 4 (2.43 ± 1.77 × 10
Identifiants
pubmed: 30841763
doi: 10.1177/1534735419833778
pmc: PMC7242777
doi:
Substances chimiques
Polyphenols
0
Benzo(a)pyrene
3417WMA06D
Cyclophosphamide
8N3DW7272P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1534735419833778Références
Inflamm Res. 2009 Sep;58(9):537-52
pubmed: 19381780
Ann Oncol. 2015 Sep;26 Suppl 5:v8-30
pubmed: 26314782
Immunopharmacol Immunotoxicol. 2017 Aug;39(4):180-187
pubmed: 28463035
Indian J Pharmacol. 2017 Jan-Feb;49(1):65-70
pubmed: 28458425
Int J Mol Sci. 2019 Jan 11;20(2):
pubmed: 30641920
Vopr Onkol. 2014;60(1):94-5
pubmed: 24772624
Clin Lymphoma. 2005 Jun;6(1):26-30
pubmed: 15989703
J Exp Clin Cancer Res. 2006 Dec;25(4):507-13
pubmed: 17310841
Exp Ther Med. 2018 Mar;15(3):3124-3132
pubmed: 29599844
Clin Pharmacokinet. 2000 Apr;38(4):291-304
pubmed: 10803453
Int J Biol Macromol. 2016 May;86:443-53
pubmed: 26836619
Hematol J. 2004;5(2):112-7
pubmed: 15048060
Chem Biol Interact. 2017 Nov 1;277:129-136
pubmed: 28918124
Curr Opin Oncol. 2004 Mar;16(2):136-40
pubmed: 15075905
Aging (Albany NY). 2016 Aug 28;8(9):1866-1875
pubmed: 27574962
Int J Mol Sci. 2018 Feb 28;19(3):
pubmed: 29495598
Biomed Pharmacother. 2019 Jan;109:1394-1405
pubmed: 30551390
Int J Biol Macromol. 2017 Jan;94(Pt A):735-744
pubmed: 27793678
J Intercult Ethnopharmacol. 2016 Jan 28;5(1):105-7
pubmed: 27069732
Int J Radiat Biol. 2018 Feb;94(2):114-123
pubmed: 29251085
Oncotarget. 2018 Apr 6;9(26):18578-18593
pubmed: 29719628